NAV: 18 Mar 2024 | ₹107.67 |
Min. SIP amount | Not Supported |
Rating | 4 |
Fund size | ₹7,131.66Cr |
1Y | 3Y | 5Y | All | |
---|---|---|---|---|
Fund returns | 57.7% | 21.1% | 23.0% | 20.8% |
Category average | 55.8% | 17.6% | 22.4% | NA |
Rank with in category | 9 | 3 | 4 | NA |
Name | Sector | Instrument | Assets |
---|---|---|---|
Sun Pharmaceutical Industries Ltd. | Healthcare | Equity | 14.51% |
Lupin Ltd. | Healthcare | Equity | 8.42% |
Cipla Ltd. | Healthcare | Equity | 6.43% |
Apollo Hospitals Enterprise Ltd. | Healthcare | Equity | 5.55% |
Dr. Reddy's Laboratories Ltd. | Healthcare | Equity | 4.95% |
Divi's Laboratories Ltd. | Healthcare | Equity | 4.41% |
Gland Pharma Ltd. | Healthcare | Equity | 4.21% |
Zydus Lifesciences Ltd. | Healthcare | Equity | 3.96% |
Abbott India Ltd. | Healthcare | Equity | 3.44% |
JB Chemicals & Pharmaceuticals Ltd. | Healthcare | Equity | 3.26% |
Inclusive of GST
Exit load of 1% if redeemed within 1 month.
0.005% (from July 1st, 2020)
Returns are taxed at 15%, if you redeem before one year. After 1 year, you are required to pay LTCG tax of 10% on returns of Rs 1 lakh+ in a financial year.
Min. for 1st investment | Not Supported |
Min. for 2nd investment onwards | Not Supported |
Min. for SIP | Not Supported |